Inhibition of the particle-associated RNA-dependent RNA polymerase activity of influenza viruses by chelating agents.
D002614:Chelating Agents / Q000494:pharmacology*; D003035:Cobalt / Q000494:pharmacology; D003300:Copper / Q000494:pharmacology; D003538:Cystamine / Q000494:pharmacology; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D004112:Dimercaprol / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D007501:Iron / Q000494:pharmacology; D008623:Mercaptoethanol / Q000494:pharmacology; D008628:Mercury / Q000494:pharmacology; D009975:Orthomyxoviridae / Q000187:drug effects / Q000201:enzymology*; D010396:Penicillamine / Q000494:pharmacology; D004369:Pentetic Acid / Q000494:pharmacology; D010618:Phenanthrolines / Q000494:pharmacology; D012118:Resorcinols / Q000494:pharmacology; D013882:Thiosemicarbazones / Q000494:pharmacology; D015032:Zinc / Q000494:pharmacology
D002614:Chelating Agents; D010618:Phenanthrolines; D012118:Resorcinols; D013882:Thiosemicarbazones; D004112:Dimercaprol; D003035:Cobalt; D008623:Mercaptoethanol; D003300:Copper; D004369:Pentetic Acid; D007501:Iron; D012321:DNA-Directed RNA Polymerases; D008628:Mercury; D010396:Penicillamine; D015032:Zinc; D003538:Cystamine